Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Barderas, Rodrigo ^a   Villar Vazquez, Roi ^a   Fernandez Acenero, Maria Jesus ^b   Babel, Ingrid ^b   Pelaez Garcia, Alberto ^c   Torres, Sofia ^a   Ignacio Casal, J ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DIAGNOSTIC AGENT; TUMOR ANTIGEN;

ANIMAL; ARTICLE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COLITIS; COLON TUMOR; DISEASE MODEL; EARLY DIAGNOSIS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY;

ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIBODIES; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; EARLY DETECTION OF CANCER; GENE EXPRESSION; HUMANS; MICE;

EID: 84900812328     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02938     Document Type: Article

References (39)

1. Scanlan, M. J. et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76, 652-658 (1998)
2. Babel, I. et al. Identification of tumor-Associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 8, 2382-2395 (2009)
3. Babel, I. et al. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol Cell Proteomics 10, M110 001784 (2011)
4. Wang, X. et al. Autoantibody signatures in prostate cancer. N Engl J Med 353, 1224-1235 (2005)
5. Chatterjee, M. et al. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66, 1181-1190 (2006)
6. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G.&Snyder, M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A 104, 17494-17499 (2007)
7. Chen, G. et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 67, 3461-3467 (2007)
8. Chapman, C. J. et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63, 228-233 (2008)
9. Crawford, L. V., Pim, D. C. &Bulbrook, R. D. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30, 403-408 (1982)
10. Chapman, C. et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18, 868-873 (2007)
11. Casal, J. I. &Barderas, R. Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing? Mol Diagn Ther 14, 149-154 (2010)
12. Neufert, C., Becker, C. &Neurath, M. F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2, 1998-2004 (2007)
13. De Robertis, M. et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog 10, 9 (2011)
14. Okayasu, I. et al. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 17, 1078-1083 (2002)
15. Corpet, D. E. &Pierre, F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-Analysis of colon chemoprevention in rats, mice and men. Eur J Cancer 41, 1911-1922 (2005)
16. Okayasu, I. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990)
17. Clapper, M. L., Cooper, H. S. &Chang, W. C. Dextran sulfate sodium-induced colitis-Associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 28, 1450-1459 (2007)
18. Cooper, H. S., Murthy, S., Kido, K., Yoshitake, H. &Flanigan, A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitisassociated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 21, 757-768 (2000)
19. Nambiar, P. R. et al. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol 22, 145-150 (2003)
20. Greten, F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-Associated cancer. Cell 118, 285-296 (2004)
21. Suzuki, R., Kohno, H., Sugie, S. &Tanaka, T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 95, 721-727 (2004)
22. Terzic, J., Grivennikov, S., Karin, E. &Karin, M. Inflammation and colon cancer. Gastroenterology 138, 2101-2114 e2105 (2010)
23. Barderas, R. et al. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-Associated antigens obtained from protein and phage microarrays. J Proteomics 75, 4647-4655 (2012)
24. Scanlan, M. J. et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62, 4041-4047 (2002)
25. Soussi, T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60, 1777-1788 (2000)
26. Qiu, J. et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 26, 5060-5066 (2008)
27. Kobold, S., Lutkens, T., Cao, Y., Bokemeyer, C. &Atanackovic, D. Autoantibodies against tumor-related antigens: incidence and biologic significance. Hum Immunol 71, 643-651 (2010)
28. Takahashi, M. &Wakabayashi, K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95, 475-480 (2004)
29. Nambiar, P. R. et al.Genetic signatures of high-And low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res 64, 6394-6401 (2004)
30. Rosenberg, D. W., Giardina, C. &Tanaka, T. Mousemodels for the study of colon carcinogenesis. Carcinogenesis 30, 183-196 (2009)
31. Cui, X. et al. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res (Phila) 3, 549-559 (2010)
32. Anderson, K. S. et al.Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 7, 1490-1499 (2008)
33. Hanahan, D.&Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011)
34. Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-Associated cancer. Cancer Cell 15, 103-113 (2009)
35. Neurath, M. F. &Finotto, S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-Associated cancer. Cytokine Growth Factor Rev 22, 83-89 (2011)
36. Wirtz, S., Neufert, C., Weigmann, B. &Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2, 541-546 (2007)
37. Pelaez-Garcia, A. et al. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer. PLoS One 8, e63695 (2013)
38. Barderas, R., Bartolome, R. A., Fernandez-Acenero, M. J., Torres, S. &Casal, J. I. High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res 72, 2780-2790 (2012)
39. Bartolome, R. A. et al. Cadherin-17 interacts with alpha2beta1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. Oncogene (2013)